Fritextsökning
Artiklar per år
Innehållstyper
-
Gothenburg, the city of life science – We are ‘Little Boston’
Western Sweden is investing in life science within everything from advanced therapeutic drugs to femtech. At the same time, stakeholders are looking to other industries for inspiration and knowledge.
-
Ranking: Top 10 highest-paid CEOs in pharma
It's nice to hear that things go well for others, right? Some of those who have done really well – at least financially – are listed here in the ranking of the best paid CEOs in Big Pharma 2023.
-
Lista: Bäst betalda toppcheferna i läkemedelsvärlden
Det är kul när det går bra för andra, eller hur? Några av dem som det gått riktigt hyggligt för – åtminstone ekonomiskt – listas här på rankningen över de bäst betalda vd:arna inom Big Pharma 2023.
-
TLV: Kostnader för läkemedel ökar allt snabbare
Kostnaderna för läkemedel fortsätter att stiga. Ökningstakten i fjol var den snabbaste under det senaste tio åren – och kommande år väntas ännu större ökningar.
-
Bio Europe to Stockholm – ”The Swedish ecosystem is now taking the opportunity”
The international life science conference Bio Europe is coming to Sweden for the first time in November. The conference, whose program takes inspiration from ABBA songs, turns 30 this year. "There is great interest in Sweden and Swedish solutions globally," says Anna Redwood from Business Sweden.
-
Setback for pharmaceutical companies in the Zantac case
A Delaware judge has ruled in favour of allowing expert witnesses to testify in a case involving the now-cancelled drug Zantac and its potential carcinogenicity.
-
Nobel Prize winner Torsten Wiesel turns 100: “Old men like me should use their experience to help the young”
In 1955, a young Torsten Wiesel jumped on a boat to the US and embarked on a fabulous career as a neuroscientist, crowned with a Nobel Prize for his work. Now 100 years old, he looks back on an intense life and his upbringing in Stockholm, Sweden, which shaped his desire to help the vulnerable in society.
-
Här är de bäst säljande läkemedlen 2023
Läkemedel från MSD, Abbvie och Novo Nordisk toppar när de läkemedel som sålde för mest förra året listas.
-
Nobelpristagaren Torsten Wiesel fyller 100: ”Gamla gubbar som jag ska använda erfarenheten till att hjälpa de unga”
Året var 1955 när en ung Torsten Wiesel hoppade på båten till USA och inledde en sagolik karriär som hjärnforskare med ett Nobelpris som kronan på verket. Nu fyller han 100 år och ser tillbaka på ett intensivt liv – och på uppväxten i Bromma som formade hans vilja att hjälpa samhällets svaga.
-
EU-valet runt hörnet – digitalisering och hälsodata i fokus
Hälsodata, digitalisering och patienters rörlighet är några av de områden där svensk sjukvård och EU möts. Det framhåller tankesmedjor med inriktning på sjukvård som Life Science Sweden pratat med.
-
Innovative start-up helps doctors, scientists and industry balance coagulation risks
For many doctors caring for seriously ill patients, for example, in stroke units and cancer wards, maintaining the life-saving balance between bleeding and thrombosis is an ongoing challenge. In the late 1980s, scientists at Maastricht University in the Netherlands developed an innovative method, the thrombin generation assay (TGA), which provides a complete overview of a physiological process crucial for maintaining normal haemostasis.
-
“Conducting research at universities is becoming more and more like working at a research hotel”
The government wants Swedish research to focus on excellence and innovation, but can the two be combined? Life Science Sweden talks to Anna Falk, a professor at Lund University, about research policy, the constant hunt for funding in academia and what constitutes ‘fine research’.
-
Samuel Lagercrantz: “Companies that do this successfully will take the lead”
The development of new medicines and medical technologies should not focus too narrowly on prolonging life. It is equally important to develop treatments that relieve pain or eliminate painful symptoms, writes Samuel Lagercrantz in an editorial.
-
Total pipeline of pharmaceutical companies reaches a record high – 22,921 medicines are currently being developed
Despite the difficult economic times, pharmaceutical companies have never developed as many new drugs as now.
-
Olinkgrundare kan få tungt europeiskt uppfinnarpris
Två av forskarna bakom Olinks succé, Ulf Landegren och Simon Fredriksson, har utsetts till finalister i European Inventor Award 2024 för sina upptäckter inom storskalig proteinanalys.
-
Läkemedelsföretagens totala pipeline rekordstor – 22 921 läkemedel utvecklas just nu
Bistra ekonomiska tider till trots. Läkemedelsföretagen har aldrig utvecklat så många nya läkemedel som nu.
-
Carl Borrebaeck – professor and serial entrepreneur with a taste for speed
Award-winning cancer researcher, the founder of many listed companies, and constantly in the academic and commercial spotlight for decades. However, Carl Borrebaeck, Professor of Immunotechnology at Lund, is not yet satisfied. “We have a new, potentially
-
Vaccinpartners på väg att bli rivaler
Franska Valneva och danska Bavarian Nordic, två partners som distribuerat och marknadsfört varandras produkter sedan 2020, kommer snart att bli rivaler inom vaccin mot chikungunyafeber.
-
Ancient DNA provides new insights – “The immune system lost its job”
Ancient bone remains from our ancestors have provided new insights into the prevalence of multiple sclerosis. By looking back in time, researchers can provide a possible explanation for why the disease is more prevalent in northern Europe.
-
Uppgift: Sanofi planerar avknoppning av sina receptfria läkemedel
Den franska läkemedelsjätten Sanofi uppges ha bett ett antal banker att pitcha för att delta i att hantera företagets planerade avknoppning av sin OTC-verksamhet, enligt källor till Bloomberg News.
-
KI’s freezer fiasco investigated: A chain of failures
A chain of combined technical and organisational shortcomings caused the freezer breakdown at the Karolinska Institute during the Christmas holidays, destroying more than 47,000 samples. This was the conclusion of an internal investigation.
-
Immunovias nya test för pankreascancer klarade målen
Lundbaserade Immunovias nya test för tidig upptäckt av bukspottkörtelcancer nådde både det primära och det sekundära effektmåttet i en modellutvecklingsstudie.
-
Nocebo – the evil twin that makes you feel worse
The placebo effect is well known in healthcare, but not so its opposite: nocebo. “The effect is small, but it can have major repercussions,” says Uppsala researcher Charlotte Blease, co-author of a book on the phenomenon.
-
Study: Popular diabetes treatment is not associated with thyroid cancer
Concerns raised about an association between GLP-1 analogues, used to treat diabetes and obesity, and an increased risk of thyroid cancer are not supported by an extensive Scandinavian study.
BREAKING